<DOC>
	<DOCNO>NCT00921037</DOCNO>
	<brief_summary>The purpose study determine whether multiple cutaneous neurofibroma patient neurofibromatosis type 1 remove erbium-YAG-laser .</brief_summary>
	<brief_title>First Clinical Study Erbium - Yttrium Aluminium Garnet ( YAG ) Laser Vaporization Cutaneous Neurofibromas</brief_title>
	<detailed_description>With prevalence 1 3-5000 birth , neurofibromatosis Type I one common genetic defect . The mode inheritance autosomal dominant affect gene ( NF1 ) , responsible production tumor suppressor protein neurofibromin . The consequence uninhibited expansion neural tissue lead amongst others cosmetic disfigurement patient . In comparison plexiform neurofibromas cutaneous tumor undergo malignant transformation . Excision CO2 laser vaporisation establish standard treatment cause unattractive scar . In one operation 500 neurofibroma remove Erbium : YAG laser ( 2940 nm ) . The tumor dissect shoot hole skin vaporise neurofibromas in-between underneath . Specimen harvest Er : YAG- , CO2 - electrosurgical treatment evaluate difference thermal necrosis histologically photograph take assess cosmetic result .</detailed_description>
	<mesh_term>Neurofibroma</mesh_term>
	<mesh_term>Neurofibromatoses</mesh_term>
	<mesh_term>Nerve Sheath Neoplasms</mesh_term>
	<criteria>Patients multiple cutaneous neurofibroma request tumor removal Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Neurofibromatosis Type 1</keyword>
	<keyword>Morbus Recklinghausen</keyword>
	<keyword>cutaneous neurofibroma</keyword>
	<keyword>Erbium-YAG-Laser</keyword>
	<keyword>Vaporisation</keyword>
	<keyword>Thermal Necrosis</keyword>
</DOC>